CCM
SGNT

Catapult Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Catapult Capital Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$920K Buy
60,000
+50,000
+500% +$1.08M 0.35% 93
2015
Q2 		$243K Buy
+10,000
New +$240K 0.03% 209
2014
Q4 		– Sell
-25,000
Closed -$778K – 246
2014
Q3 		$778K Sell
25,000
-40,000
-62% -$1.08M 0.08% 159
2014
Q2 		$1.68M Buy
+65,000
New +$1.44M 0.19% 139

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Catapult Capital Management's SGNT Position: Q3 2015 in Review

Catapult Capital Management increased its SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) stake by 500% in Q3 2015, buying an estimated $1.08M and bringing the position to 60,000 shares worth $920K. The position accounts for 0.35% of the portfolio, ranked #93.

Catapult Capital Management first reported a position in SGNT in Q2 2014 and has held it in 4 quarters since. The position peaked at $1.68M in Q2 2014. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • Catapult Capital Management held 60,000 shares of SAGENT PHARMACEUTICALS INC COM STK (DE) worth $920K as of Q3 2015.
  • Catapult Capital Management bought 50,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $1.08M.
  • SAGENT PHARMACEUTICALS INC COM STK (DE) made up 0.35% of Catapult Capital Management's portfolio in Q3 2015, its #93 holding.
  • Catapult Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and has held it in 4 quarters since.
  • Catapult Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.68M in Q2 2014.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.